These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15672334)

  • 61. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.
    Harrison L; McGinnis J; Crowther M; Ginsberg J; Hirsh J
    Arch Intern Med; 1998 Oct; 158(18):2001-3. PubMed ID: 9778199
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cost for inpatient care of venous thrombosis: a trial of enoxaparin vs standard heparin.
    de Lissovoy G; Yusen RD; Spiro TE; Krupski WC; Champion AH; Sorensen SV
    Arch Intern Med; 2000 Nov; 160(20):3160-5. PubMed ID: 11074747
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism.
    Lefebvre P; Coleman CI; Bookhart BK; Wang ST; Mody SH; Tran KN; Zhuo DY; Huynh L; Nutescu EA
    J Med Econ; 2014 Jan; 17(1):52-64. PubMed ID: 24156243
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Oral rivaroxaban for symptomatic venous thromboembolism.
    ; Bauersachs R; Berkowitz SD; Brenner B; Buller HR; Decousus H; Gallus AS; Lensing AW; Misselwitz F; Prins MH; Raskob GE; Segers A; Verhamme P; Wells P; Agnelli G; Bounameaux H; Cohen A; Davidson BL; Piovella F; Schellong S
    N Engl J Med; 2010 Dec; 363(26):2499-510. PubMed ID: 21128814
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Outpatient management of acute deep vein thrombosis: results from the OTIS-DVT registry.
    Spirk D; Banyai M; Jacomella V; Frank U; Baldi T; Baumgartner I; Amann-Vesti B; Kucher N; Husmann M
    Thromb Res; 2011 May; 127(5):406-10. PubMed ID: 21296385
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Systematic Review of Real-World Studies Evaluating Characteristics Associated With or Programs Designed to Facilitate Outpatient Management of Deep Vein Thrombosis.
    Weeda ER; Butt S
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):301S-313S. PubMed ID: 30428693
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine].
    Manganaro A; Giannino D; Lembo D; Bruni F; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):41-51. PubMed ID: 11253339
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness of enoxaparin versus low-dose heparin for prophylaxis against venous thrombosis after major trauma.
    Devlin JW; Petitta A; Shepard AD; Obeid FN
    Pharmacotherapy; 1998; 18(6):1335-42. PubMed ID: 9855335
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Thromboprophylaxis with 60 mg enoxaparin is safe in hip trauma surgery.
    Thaler HW; Roller RE; Greiner N; Sim E; Korninger C
    J Trauma; 2001 Sep; 51(3):518-21. PubMed ID: 11535902
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program.
    Groce JB
    Pharmacotherapy; 1998; 18(6 Pt 3):175S-180S. PubMed ID: 9853912
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Warfarin vs enoxaparin for deep venous thrombosis prophylaxis after total hip & total knee arthroplasty: a cost comparison.
    Garcia-Zozaya I
    J Ky Med Assoc; 1998 Apr; 96(4):143-8. PubMed ID: 9577110
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The post-discharge prophylactic management of the orthopedic patient with low-molecular-weight heparin: enoxaparin.
    Nilsson PE; Bergqvist D; Benoni G; Björgell O; Fredin H; Hedlund U; Nicolas S; Nylander G
    Orthopedics; 1997 Feb; 20 Suppl():22-5. PubMed ID: 9048404
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The post-hospital discharge venous thrombosis risk of the orthopedic patient.
    Planes A; Vochelle N
    Orthopedics; 1997 Feb; 20 Suppl():18-21. PubMed ID: 9048403
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enoxaparin and heparin comparison of deep vein thrombosis prophylaxis in total hip replacement patients.
    Senaran H; Acaroğlu E; Ozdemir HM; Atilla B
    Arch Orthop Trauma Surg; 2006 Jan; 126(1):1-5. PubMed ID: 16333632
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Is heparin treatment the optimal management for cerebral venous thrombosis? Effect of abciximab, recombinant tissue plasminogen activator, and enoxaparin in experimentally induced superior sagittal sinus thrombosis.
    Röttger C; Madlener K; Heil M; Gerriets T; Walberer M; Wessels T; Bachmann G; Kaps M; Stolz E
    Stroke; 2005 Apr; 36(4):841-6. PubMed ID: 15731475
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cost-Effectiveness Analysis of Rivaroxaban for Treatment of Deep Vein Thrombosis and Pulmonary Embolism in Greece.
    Gourzoulidis G; Kourlaba G; Kakisis J; Matsagkas M; Giannakoulas G; Gourgoulianis KI; Vassilakopoulos T; Maniadakis N
    Clin Drug Investig; 2017 Sep; 37(9):833-844. PubMed ID: 28608312
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Outpatient-based treatment protocols in the management of venous thromboembolic disease.
    Spyropoulos AC
    Am J Manag Care; 2000 Nov; 6(20 Suppl):S1034-44. PubMed ID: 11484303
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Enoxaparin for thromboprophylaxis after major trauma: potential cost implications.
    Shorr AF; Ramage AS
    Crit Care Med; 2001 Sep; 29(9):1659-65. PubMed ID: 11546959
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs.
    Lozano F; Trujillo-Santos J; Barrón M; Gallego P; Babalis D; Santos M; Falgá C; Monreal M;
    J Vasc Surg; 2014 May; 59(5):1362-7.e1. PubMed ID: 24439322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.